Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas;
Department of Nephrology and Hypertension and Institute of Biochemistry and Molecular Medicine, Inselspital, University of Bern, Bern, Switzerland.
Am J Physiol Renal Physiol. 2014 Nov 1;307(9):F1063-71. doi: 10.1152/ajprenal.00408.2014. Epub 2014 Aug 27.
Congenital distal renal tubular acidosis (RTA) from mutations of the B1 subunit of V-ATPase is considered an autosomal recessive disease. We analyzed a distal RTA kindred with a truncation mutation of B1 (p.Phe468fsX487) previously shown to have failure of assembly into the V1 domain of V-ATPase. All heterozygous carriers in this kindred have normal plasma HCO3- concentrations and thus evaded the diagnosis of RTA. However, inappropriately high urine pH, hypocitraturia, and hypercalciuria were present either individually or in combination in the heterozygotes at baseline. Two of the heterozygotes studied also had inappropriate urinary acidification with acute ammonium chloride loading and an impaired urine-blood Pco2 gradient during bicarbonaturia, indicating the presence of a H+ gradient and flux defects. In normal human renal papillae, wild-type B1 is located primarily on the plasma membrane, but papilla from one of the heterozygote who had kidney stones but not nephrocalcinosis showed B1 in both the plasma membrane as well as diffuse intracellular staining. Titration of increasing amounts of the mutant B1 subunit did not exhibit negative dominance over the expression, cellular distribution, or H+ pump activity of wild-type B1 in mammalian human embryonic kidney-293 cells and in V-ATPase-deficient Saccharomyces cerevisiae. This is the first demonstration of renal acidification defects and nephrolithiasis in heterozygous carriers of a mutant B1 subunit that cannot be attributable to negative dominance. We propose that heterozygosity may lead to mild real acidification defects due to haploinsufficiency. B1 heterozygosity should be considered in patients with calcium nephrolithiasis and urinary abnormalities such as alkalinuria or hypocitraturia.
先天性远端肾小管酸中毒(RTA)是由于 V-ATPase 的 B1 亚基突变引起的,被认为是一种常染色体隐性疾病。我们分析了一个具有 B1 截断突变(p.Phe468fsX487)的远端 RTA 家族,该突变先前被证明无法组装到 V-ATPase 的 V1 结构域。该家族中的所有杂合子携带者的血浆 HCO3-浓度均正常,因此未能诊断为 RTA。然而,在基线时,杂合子个体中单独或组合存在不适当的尿 pH 值升高、尿柠檬酸盐减少和高钙尿症。在研究的两个杂合子中,急性氯化铵负荷后尿酸化不适当,碳酸氢盐尿期间尿-血 Pco2 梯度受损,表明存在 H+梯度和流量缺陷。在正常人的肾乳头中,野生型 B1 主要位于质膜上,但来自一个有肾结石但无肾钙质沉着症的杂合子的肾乳头显示 B1 既存在于质膜上,也存在于弥漫性细胞内染色中。增加突变 B1 亚基的量滴定并未表现出对哺乳动物人胚肾-293 细胞和 V-ATPase 缺陷型酿酒酵母中野生型 B1 的表达、细胞分布或 H+泵活性的负显性。这是首次证明在不能归因于负显性的突变 B1 亚基杂合子中存在肾酸化缺陷和肾结石形成。我们提出,杂合性可能导致由于单倍不足引起的轻度真实酸化缺陷。在有钙肾结石和尿异常(如碱化尿或柠檬酸盐减少)的患者中应考虑 B1 杂合性。